CAT and colorectal carcinoma: Performing ELISA-based assays in a larger cohorts would not only show whether REG4 and A1AT are good CAT biomarkers in CRC, including other cancer types in the cohort would also show whether REG4 and A1AT would be applicable as CAT biomarkers in other cancer types as well.